ELMD

#3251
Electromed, Inc. Common Stock
39.5 5 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
39.26
40.52
Year Range
23.01
47.37
Daily Change
-1.13%
Monthly Change
+1.44%
6 month change
+65.20%
Year Change
+59.60%
Previous Close
40.0 0
Open
40.2 8
Low
39.2 6
High
40.5 2
Volume
90
Open full chart

Financials

Overview Statement Statistics Documents

2026

Current report, Q2 FY2026
Electromed, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q3 FY2026
Electromed, Inc. quarterly report, Q3 FY2026
10-Q
Current report, Q1 FY2026
Electromed, Inc. current report, Q1 FY2026
8-K

2025

Quarterly report, Q2 FY2026
Electromed, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q4 FY2025
Electromed, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Electromed, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Electromed, Inc. current report, Q4 FY2025
8-K
Quarterly report, Q1 FY2026
Electromed, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q3 FY2025
Electromed, Inc. current report, Q3 FY2025
8-K
Current report, Q3 FY2025
Electromed, Inc. current report, Q3 FY2025
8-K

Electromed, Inc. current report, Q4 FY2025

Full document

Electromed, Inc. (ELMD) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K, dated November 14, 2025, details the results of the annual meeting of shareholders held on that date. The filing covers the election of directors, ratification of the independent auditor, and advisory votes on executive compensation.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.

Material Changes and Voting Results

  • Director Elections: All eight nominees were elected to the Board of Directors for a one-year term. The nominees are James L. Cunniff, Stan K. Erickson, Gregory J. Fluet, Joseph L. Galatowitsch, Kathleen S. Skarvan, Andrew J. Summers, Kathleen A. Tune, and Andrea M. Walsh.
  • Auditor Ratification: Shareholders ratified the appointment of RSM US LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
  • Executive Compensation (Say-on-Pay): Shareholders approved the executive compensation plan on a non-binding advisory basis.
  • Frequency of Say-on-Pay: Shareholders recommended that votes on named executive officer compensation occur annually.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The Board has determined to continue including an annual shareholder vote on executive compensation based on the advisory results.

Key Facts for Investor Verification

  • Verify the total number of shares outstanding and the percentage of votes cast for each director nominee to assess shareholder support levels.
  • Confirm the specific terms of the engagement with RSM US LLP for the fiscal year ending June 30, 2026.
  • Review the definitive proxy statement filed on September 30, 2025, for detailed descriptions of the director nominees and executive compensation proposals.
  • Note the significant number of broker non-votes (1,416,368) recorded for the director elections and compensation proposals.

News